当前位置: 首页 >> 检索结果
3264. Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
作者: B Joseph Elmunzer.;Lydia D Foster.;Jose Serrano.;Gregory A Coté.;Steven A Edmundowicz.;Sachin Wani.;Raj Shah.;Ji Young Bang.;Shyam Varadarajulu.;Vikesh K Singh.;Mouen Khashab.;Richard S Kwon.;James M Scheiman.;Field F Willingham.;Steven A Keilin.;Georgios I Papachristou.;Amitabh Chak.;Adam Slivka.;Daniel Mullady.;Vladimir Kushnir.;James Buxbaum.;Rajesh Keswani.;Timothy B Gardner.;Nauzer Forbes.;Amit Rastogi.;Andrew Ross.;Joanna Law.;Patrick Yachimski.;Yen-I Chen.;Alan Barkun.;Zachary L Smith.;Bret Petersen.;Andrew Y Wang.;John R Saltzman.;Rebecca L Spitzer.;Collins Ordiah.;Cathie Spino.;Valerie Durkalski-Mauldin.; .
来源: Lancet. 2024年403卷10425期450-458页
The combination of rectally administered indomethacin and placement of a prophylactic pancreatic stent is recommended to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients. Preliminary evidence suggests that the use of indomethacin might eliminate or substantially reduce the need for stent placement, a technically complex, costly, and potentially harmful intervention.
3270. Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis.
作者: Antonio Landi.;Giovanni Pedrazzini.;Léa Wild.;Alicia Beele.;Matteo Nafi.;Michael Joner.;Marco Valgimigli.
来源: Lancet. 2024年403卷10422期e5-e6页 |